Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta.
Zeender, E
Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta. [electronic resource] - The Journal of clinical endocrinology and metabolism Oct 2004 - 5059-66 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0021-972X
10.1210/jc.2004-0446 doi
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Apoptosis--drug effects
Cells, Cultured
Glucose--pharmacology
Humans
Hypoglycemic Agents--pharmacology
Insulin--metabolism
Insulin Secretion
Interleukin-1--metabolism
Islets of Langerhans--cytology
NF-kappa B--metabolism
Nitric Oxide--metabolism
Pioglitazone
Sodium Salicylate--pharmacology
Thiazolidinediones--pharmacology
Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta. [electronic resource] - The Journal of clinical endocrinology and metabolism Oct 2004 - 5059-66 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0021-972X
10.1210/jc.2004-0446 doi
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Apoptosis--drug effects
Cells, Cultured
Glucose--pharmacology
Humans
Hypoglycemic Agents--pharmacology
Insulin--metabolism
Insulin Secretion
Interleukin-1--metabolism
Islets of Langerhans--cytology
NF-kappa B--metabolism
Nitric Oxide--metabolism
Pioglitazone
Sodium Salicylate--pharmacology
Thiazolidinediones--pharmacology